Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $11.36 Billion |
|---|---|
| Enterprise Value | $10.59 Billion |
| Annual dividend | $0.25 |
| Dividend yield | 1.15% |
| Earnings per Share | $0.73 |
| Beta | 0.37 |
| Outstanding Shares | 523,583,999 |
| P/E Ratio | 26.49 |
|---|---|
| PEG | 445.55 |
| Price to Sales | 10.85 |
| Price to Book Ratio | 4.34 |
| Enterprise Value to Revenue | 9.47 |
| Enterprise Value to EBIT | 22.11 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed ...